Engineering Human Myocardium: Integrating the Maturation of hiPSC-Derived Cardiac Myocytes Across Genetic, Structural, Physiological and Multicellular Systems
Cells · 01.06.2026 · 15 (11) · 1019
DOI: 10.3390/cells15111019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 01.06.2026. Verfasst von Nora Hosny und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Induced Pluripotent Stem Cells, Tissue Engineering, Myocardium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, American Heart Association, Muscular Dystrophy Association.
Abstract (Originalsprache)
The landscape of human cardiac biology was transformed by the discovery that adult somatic cells can be reprogrammed into induced pluripotent stem cells, enabling patient-specific disease modeling, drug testing, and regenerative strategies without the prior ethical or biological constraints. Subsequent advances in directed differentiation made the generation of human iPSC-derived cardiac myocytes reliable and scalable. Despite this progress, a central limitation has remained: these cells are developmentally immature, resembling fetal cardiac myocytes in structure, metabolism, and function. This immaturity restricts their utility for modeling adult-onset disease, predicting drug responses, and achieving clinical translation. Maturation is now understood as a multifactorial symphony, requiring coordinated molecular, structural, and environmental inputs rather than single interventions. As a result, the field is shifting toward integrative approaches that incorporate 3D architecture, multicellular systems, and biomimetic environments to better replicate native cardiac tissue. While fully adult-like myocardium remains an ongoing goal, advances in bioengineering and system-level design are narrowing the gap, with success increasingly defined by the generation of functional cardiac tissue rather than isolated cell maturity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
- Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
ORCID-Profile: Nora Hosny, John Bauer, Joseph M Metzger
Förderung
- NIH HHS
- American Heart Association
- Muscular Dystrophy Association
- NIH
- MDA
- Gregory Marzolf Jr. Foundation
- University of Minnesota
Zitieren
APA
Hosny, N., Cohen, H., Bauer, J., Schreifels, J., Lin, R., Thompson, B. R., & Metzger, J. M. (2026). Engineering Human Myocardium: Integrating the Maturation of hiPSC-Derived Cardiac Myocytes Across Genetic, Structural, Physiological and Multicellular Systems. Cells, 15(11), 1019. https://doi.org/10.3390/cells15111019
Vancouver
Hosny N, Cohen H, Bauer J, Schreifels J, Lin R, Thompson BR, et al. Engineering Human Myocardium: Integrating the Maturation of hiPSC-Derived Cardiac Myocytes Across Genetic, Structural, Physiological and Multicellular Systems. Cells. 2026;15(11):1019. doi:10.3390/cells15111019
BibTeX
@article{Hosny2026,
author = {Hosny, Nora and Cohen, Houda and Bauer, John and Schreifels, Jeff and Lin, Rachel and Thompson, Brian R and Metzger, Joseph M},
title = {Engineering Human Myocardium: Integrating the Maturation of hiPSC-Derived Cardiac Myocytes Across Genetic, Structural, Physiological and Multicellular Systems},
journal = {Cells},
year = {2026},
volume = {15},
number = {11},
pages = {1019},
doi = {10.3390/cells15111019}
}
EUVIMED